Related Experiment Video
Updated: Jul 5, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Actions speak louder than ORFs: A non-canonical microprotein promotes medulloblastoma oncogenesis
Alberto Delaidelli1, Jessica Oliveira de Santis2, Poul H Sorensen1
1Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver British Columbia V5Z 1L3, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver British Columbia V6T 1Z4, Canada.
Abstract:
In this issue of Molecular Cell, Hofman et al.1 identify the translation of a non-canonical upstream open reading frame of the ASNSD1 gene into a microprotein that supports medulloblastoma growth.
Insights
Researchers found that a small protein, translated from a non-canonical upstream open reading frame of the ASNSD1 gene, supports medulloblastoma growth. This microprotein plays a key role in supporting the development of this brain tumor.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Medulloblastoma is a common pediatric brain tumor.
- The ASNSD1 gene is implicated in cellular metabolism and cancer.
- Non-canonical translation mechanisms are increasingly recognized in cancer biology.
Purpose of the Study:
- To investigate the functional role of upstream open reading frames (uORFs) in ASNSD1 gene expression.
- To identify novel microproteins involved in medulloblastoma pathogenesis.
- To explore new therapeutic targets for medulloblastoma.
Main Methods:
- Analysis of ASNSD1 gene transcripts and translation products.
- Use of cell culture models of medulloblastoma.
- CRISPR-Cas9 gene editing to assess microprotein function.
- Western blotting and mass spectrometry to detect microproteins.
Main Results:
- Identification of a novel microprotein translated from a non-canonical uORF of ASNSD1.
- Demonstration that this microprotein supports medulloblastoma cell proliferation and survival.
- Evidence that the microprotein enhances tumor growth in preclinical models.
Conclusions:
- The ASNSD1 uORF-derived microprotein is a novel driver of medulloblastoma.
- Targeting this microprotein may represent a new therapeutic strategy for medulloblastoma.
- This study highlights the importance of non-canonical translation in cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Destabilization of Microtubules
Induced Pluripotent Stem Cells
Somatic...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

